|
|
H2021/CTD8748/20414EUA
|
TOZINAMERAN COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) COMIRNATY®
|
SINGLE-STRANDED, 5’-CAPPED MESSENGER RNA (MRNA) PRODUCED USING A CELL-FREE IN VITRO TRANSCRIPTION FROM THE CORRESPONDING DNA TEMPLATES, ENCODING THE VIRAL SPIKE (S) PROTEIN OF SARS-COV-2.
|
MINISTRY OF HEALTH HEADQUARTERS (AFYA HSE)
|
Revoked
|
Details →
|
|
|
H2021/CTD8835/20517EUA
|
COVID-19 VACCINE MODERNA DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)
|
MESSENGER RNA (MRNA) (EMBEDDED IN SM-102 LIPID NANOPARTICLES). SINGLE-STRANDED, 5’-CAPPED MESSENGER RNA (MRNA) PRODUCED USING A CELL-FREE IN VITRO TRANSCRIPTION FROM THE CORRESPONDING DNA TEMPLATES, ENCODING THE VIRAL SPIKE (S) PROTEIN OF SARS-COV-2.
|
MINISTRY OF HEALTH HEADQUARTERS (AFYA HSE)
|
Revoked
|
Details →
|
|
|
H2021/CTD8749/20408EUA
|
COVID-19 VACCINE (VERO CELL), INACTIVATED
|
INACTIVATED SARS-COV-2 VIRUS (19NCOV-CDC-TAN-HB02 STRAIN)
|
MINISTRY OF HEALTH HEADQUARTERS (AFYA HSE)
|
Revoked
|
Details →
|
|
|
H2021/CTD8797/20471EUA
|
NOVEL ORAL POLIOMYELITIS VACCINE TYPE 2 (NOPV2)
|
LIVE ATTENUATED POLIOMYELITIS VIRUS TYPE 2 PREPARED IN MONKEY KIDNEY CELLS
|
MINISTRY OF HEALTH HEADQUARTERS (AFYA HSE)
|
Revoked by PPB
|
Details →
|
|
|
H2025/CTD12553/27538EUA
|
IMVANEX
|
LIVE MODIFIED VACCINIA VIRUS ANKARA)
|
MINISTRY OF HEALTH HEADQUARTERS (SDPHPS)
|
Authorized
|
Details →
|